drugset / Trial / NCT00610714
AZD0530 Phase II Study in Patients With Advanced Ovarian Cancer
RandomizedParallel-groupTriple-blindTreatment
Summary
The main purpose of this study is to determine if AZD0530 can improve the efficacy of standard chemotherapy for the treatment of ovarian cancer
Timeline
- Start
- 2008-04
- Primary completion
- 2009-08
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | saracatinib | Small molecule | — | — |
| Background | Carboplatin | Small molecule | — | Intravenous |
| Background | Paclitaxel | Small molecule | — | Intravenous |